Last reviewed · How we verify
NCT06112184
Digital Health Program With Participants Using an Autoinjector
NA trial testing SK-M11/3A1 Digital health program in Immune-Mediated Inflammatory Disease in 27 participants. Completed in 1 October 2024.
1 October 2024
Quick facts
| Lead sponsor | Sidekick Health |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 27 |
| Start date | 10 December 2023 |
| Primary completion | 1 October 2024 |
| Estimated completion | 1 October 2024 |
| Sites | 1 location across Iceland |
Drugs / interventions tested
- SK-M11/3A1 Digital health program
Conditions studied
- Immune-Mediated Inflammatory Disease — all drugs for Immune-Mediated Inflammatory Disease →
Sponsor
Sidekick Health
Who can join
18 and older, any sex, with Immune-Mediated Inflammatory Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, single-arm, feasibility study. Up to thirty (30) participants meeting study eligibility criteria will use the SK-M11/3A1 digital health program for 12 weeks. The program will be delivered via the Sidekick mobile application (app). The study objective is to evaluate the performance and safety of the SK-M11/3A1 digital health program when added to routine medical treatment of patients with Immune-Mediated Inflammatory Disease (IMID). All participants are using a prescribed medication for regular subcutaneous injection provided in a prefilled autoinjector.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06112184
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Sidekick Health trials
Trials by the same sponsor.
- NCT06989450 — Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for · NA · recruiting
- NCT05801965 — A Digital Therapeutic Solution for Cancer Patients · NA · completed
- NCT05713565 — A Digital Care Solution for Coronary Artery Disease Patients · NA · completed
- NCT05459454 — A Digital Solution for Breast Cancer Patients · NA · completed
- NCT05426382 — A Digital Solution for Individuals With Non Alcoholic Fatty Liver Disease · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06112184 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sidekick Health
- Last refreshed: 25 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06112184.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing